The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection

Journal of Clinical Apheresis

Volumn 27, Issue 4, 2012, Pages 173-177

  Ahmed, Tahmeena ^a   Senzel, Lisa ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

immunoadsorption; plasmapheresis; renal; transplantation

Indexed keywords

BORTEZOMIB; CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C4D; FRESH FROZEN PLASMA; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; RITUXIMAB;

ACUTE ANTIBODY MEDIATED KIDNEY GRAFT REJECTION; ACUTE GRAFT REJECTION; APHERESIS; CLINICAL EFFECTIVENESS; EARLY TERMINATION OF CLINICAL TRIAL; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LEUKOCYTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; REVIEW; T CELL DEPLETION;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD COMPONENT REMOVAL; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE DONORS;

EID: 84864655098     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21211     Document Type: Review

References (26)

1. Bartel G, Schwaiger E, Bohmig GA,. Prevention and treatment of alloantibody-mediated kidney transplant rejection. Transpl Int 2011; 24: 1142-1155.
2. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 142.
3. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K,. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714. (Pubitemid 36745243)
4. George SM, Balogun RA, Sanoff SL,. Therapeutic apheresis before and after kidney transplantation. J Clin Apher 2011; 26: 252-260.
5. Lehrich RW, Rocha PN, Reinsmoen N, Greenberg A, Butterly DW, Howell DN, Smith SR,. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 2005; 66: 350-358. (Pubitemid 40615789)
6. White NB, Greenstein SM, Cantafio AW, Schechner R, Glicklich D, McDonough P, Pullman J, Mohandas K, Boctor F, Uehlinger J, Tellis V,. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004; 78: 772-774. (Pubitemid 39244747)
7. Ibernon M, Gil-Vernet S, Carrera M, Seron D, Moreso F, Bestard O, Cruzado JM, Grinyo JM,. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 2005; 37: 3743-3745. (Pubitemid 43015152)
8. Pascual M, Saidman S, Tolkoff-Rubin N, Williams WW, Mauiyyedi S, Duan JM, Farrell ML, Colvin RB, Cosimi AB, Delmonico FL,. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66: 1460-1464. (Pubitemid 29014024)
9. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, Farrell ML, Williams WW, Delmonico FL, Cosimi AB, Colvin RB, Saidman SL,. Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658. (Pubitemid 32268068)
10. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE,. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887-895.
11. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ,. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol: JASN 2002; 13: 242-251. (Pubitemid 34042034)
12. Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB,. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998; 66: 800-805.
13. Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN, Smith SR,. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003; 75: 1490-1495. (Pubitemid 36597283)
14. Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS,. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 2004; 77: 1399-1405. (Pubitemid 38668435)
15. Becker YT, Becker BN, Pirsch JD, Sollinger HW,. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004; 4: 996-1001. (Pubitemid 38745599)
16. Faguer S, Kamar N, Guilbeaud-Frugier C, Fort M, Modesto A, Mari A, Ribes D, Cointault O, Lavayssiere L, Guitard J, Durand D, Rostaing L,. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277-1280. (Pubitemid 46743692)
17. Raghavan R, Jeroudi A, Achkar K, Gaber AO, Patel SJ, Abdellatif A,. Bortezomib in kidney transplantation. J Transplant 2010; 2010: 698594. DOI: 10.1155/2010/698594.
18. Lucas JG, Co JP, Nwaogwugwu UT, Dosani I, Sureshkumar KK,. Antibody-mediated rejection in kidney transplantation: an update. Expert Opin Pharmacotherapy 2011; 12: 579-592.
19. Singh N, Pirsch J, Samaniego M,. Antibody-mediated rejection: treatment alternatives and outcomes. Transplant Rev (Orlando) 2009; 23: 34-46.
20. Jordan SC, Reinsmoen N, Peng A, Lai CH, Cao K, Villicana R, Toyoda M, Kahwaji J, Vo AA,. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol; 25: 2035-2045; quiz 2045-2038.
21. Sun Q, Liu ZH, Yin G, Chen H, Chen J, Ji S, Li LS,. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 2006; 21: 510-517.
22. Bohmig GA, Wahrmann M, Regele H, Exner M, Robl B, Derfler K, Soliman T, Bauer P, Mullner M, Druml W,. Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant 2007; 7: 117-121. (Pubitemid 44952863)
23. Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C,. Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 2009; 9: 1099-1107.
24. Kaposztas Z, Podder H, Mauiyyedi S, Illoh O, Kerman R, Reyes M, Pollard V, Kahan BD,. Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant 2009; 23: 63-73.
25. Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, Mejean A, Charron D, Duong van Huyen JP, Bruneval P, Legendre C, Nochy D,. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
26. Loupy A, Suberbielle-Boissel C, Zuber J, Anglicheau D, Timsit MO, Martinez F, Thervet E, Bruneval P, Charron D, Hill GS, Nochy D, Legendre C,. Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study. Transplantation 2010; 89: 1403-1410.